GlassScriptPhysician profile
Elizabeth Tracy
NPI 1174588529
$4,305.01
in general payments reported to CMS, 2019-2025
40 companies · $872 in 2025
The $872 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $277 · 2021: $750 · 2022: $666 · 2023: $474 · 2024: $414 · 2025: $872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693 · Education: $66.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.04 |
| Education | $66.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $900.36 | 2019-2025 | Ubrelvy |
| Astellas Pharma US INC | $373.63 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $364.93 | 2019-2025 | |
| Daiichi Sankyo INC. | $267.44 | 2019-2022 | |
| Biogen, INC. | $245.43 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $233.28 | 2019-2022 | |
| Organon LLC | $181.32 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $144.79 | 2019-2025 | |
| Millicent US INC | $143.50 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Coopersurgical, INC. | $141.30 | 2019-2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $122.60 | 2022-2025 | Phexxi, Solosec, Phexx |
| Galderma Laboratories, L.P. | $113.43 | 2022-2023 | Dysport |
| Hologic Sales and Service, LLC | $96.86 | 2019-2025 | Aptima |
| Idorsia Pharmaceuticals US INC | $79.32 | 2022-2024 | Quviviq |
| Merck Sharp & Dohme LLC | $70.17 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.